These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
766 related articles for article (PubMed ID: 30965100)
1. Resistance of Candida to azoles and echinocandins worldwide. Pristov KE; Ghannoum MA Clin Microbiol Infect; 2019 Jul; 25(7):792-798. PubMed ID: 30965100 [TBL] [Abstract][Full Text] [Related]
2. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans. Castanheira M; Deshpande LM; Davis AP; Rhomberg PR; Pfaller MA Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784671 [TBL] [Abstract][Full Text] [Related]
4. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
5. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009). Pfaller MA; Messer SA; Moet GJ; Jones RN; Castanheira M Int J Antimicrob Agents; 2011 Jul; 38(1):65-9. PubMed ID: 21514797 [TBL] [Abstract][Full Text] [Related]
6. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance. Chowdhary A; Prakash A; Sharma C; Kordalewska M; Kumar A; Sarma S; Tarai B; Singh A; Upadhyaya G; Upadhyay S; Yadav P; Singh PK; Khillan V; Sachdeva N; Perlin DS; Meis JF J Antimicrob Chemother; 2018 Apr; 73(4):891-899. PubMed ID: 29325167 [TBL] [Abstract][Full Text] [Related]
7. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment. Jensen RH Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142 [TBL] [Abstract][Full Text] [Related]
8. Antifungal susceptibility of Candida species isolated from patients with candidemia in southern Taiwan, 2007-2012: impact of new antifungal breakpoints. Chen YC; Kuo SF; Chen FJ; Lee CH Mycoses; 2017 Feb; 60(2):89-95. PubMed ID: 27621210 [TBL] [Abstract][Full Text] [Related]
9. Loss of C-5 Sterol Desaturase Activity Results in Increased Resistance to Azole and Echinocandin Antifungals in a Clinical Isolate of Candida parapsilosis. Rybak JM; Dickens CM; Parker JE; Caudle KE; Manigaba K; Whaley SG; Nishimoto AT; Luna-Tapia A; Roy S; Zhang Q; Barker KS; Palmer GE; Sutter TR; Homayouni R; Wiederhold NP; Kelly SL; Rogers PD Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630186 [TBL] [Abstract][Full Text] [Related]
10. New and Promising Chemotherapeutics for Emerging Infections Involving Drug-resistant Non-albicans Candida Species. Silva LN; de Mello TP; de Souza Ramos L; Branquinha MH; Dos Santos ALS Curr Top Med Chem; 2019; 19(28):2527-2553. PubMed ID: 31654512 [TBL] [Abstract][Full Text] [Related]
11. Commonly Used Oncology Drugs Decrease Antifungal Effectiveness against Candida and Aspergillus Species. Butts A; Reitler P; Ge W; Fortwendel JR; Palmer GE Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712657 [TBL] [Abstract][Full Text] [Related]
12. Activity of Combined Antifungal Agents Against Multidrug-Resistant Candida glabrata Strains. Denardi LB; Keller JT; Oliveira V; Mario DAN; Santurio JM; Alves SH Mycopathologia; 2017 Oct; 182(9-10):819-828. PubMed ID: 28493006 [TBL] [Abstract][Full Text] [Related]
13. Spectrum of activity and mechanisms of azole-bisphosphonate synergy in pathogenic Kane A; Dinh H; Campbell L; Cain AK; Hibbs D; Carter D Microbiol Spectr; 2024 Jun; 12(6):e0012124. PubMed ID: 38695556 [TBL] [Abstract][Full Text] [Related]
14. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012. Pfaller MA; Castanheira M; Messer SA; Jones RN Mycoses; 2015 Apr; 58(4):209-14. PubMed ID: 25727853 [TBL] [Abstract][Full Text] [Related]
15. Candida auris and multidrug resistance: Defining the new normal. Lockhart SR Fungal Genet Biol; 2019 Oct; 131():103243. PubMed ID: 31228646 [TBL] [Abstract][Full Text] [Related]
16. Identification of genetic markers of resistance to echinocandins, azoles and 5-fluorocytosine in Candida glabrata by next-generation sequencing: a feasibility study. Biswas C; Chen SC; Halliday C; Kennedy K; Playford EG; Marriott DJ; Slavin MA; Sorrell TC; Sintchenko V Clin Microbiol Infect; 2017 Sep; 23(9):676.e7-676.e10. PubMed ID: 28344162 [TBL] [Abstract][Full Text] [Related]
20. In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis. Boikov DA; Locke JB; James KD; Bartizal K; Sobel JD J Antimicrob Chemother; 2017 May; 72(5):1355-1358. PubMed ID: 28158577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]